Cargando…

Novel immunotherapy in metastatic renal cell carcinoma

Despite the rapid development of therapeutic modalities for metastatic renal cell carcinoma (mRCC) over the past decade to include a number of targeted antiangiogenic therapies and traditional immunotherapy, such as high-dose interleukin-2 and interferon-α, mRCC continues to be associated with poor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Yang Hyun, Kim, Myung Soo, Chung, Ho Seok, Hwang, Eu Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494344/ https://www.ncbi.nlm.nih.gov/pubmed/28681030 http://dx.doi.org/10.4111/icu.2017.58.4.220

Ejemplares similares

A rare presentation of metastatic prostate cancer, initially a suspect for urothelial cell carcinoma of the ureter: a case report
por: Chung, Ho Seok, et al.
Publicado: (2017)

Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib
por: Kim, Myung Soo, et al.
Publicado: (2018)

Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy
por: Kim, Sung Han, et al.
Publicado: (2021)

Analysis of Changes in the Total Lymphocyte and Eosinophil Count during Immunotherapy for Metastatic Renal Cell Carcinoma: Correlation with Response and Survival
por: Jeong, In Gab, et al.
Publicado: (2007)

Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
por: Shao, Zhiying, et al.
Publicado: (2016)

Optimal management of renal cell carcinoma in octogenarians: Retrospective analysis using updated Korean Renal Cell Carcinoma (KORCC) database
por: Kim, Jung Kwon, et al.
Publicado: (2023)

A Retrospective, Multicenter, Long-Term Follow-Up Analysis of the Prognostic Characteristics of Recurring Non-Metastatic Renal Cell Carcinoma After Partial or Radical Nephrectomy
por: Kim, Sung Han, et al.
Publicado: (2021)

The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy
por: Chung, Jae-Wook, et al.
Publicado: (2020)

Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
por: Kim, Sung Han, et al.
Publicado: (2019)

Publisher Correction: Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy
por: Lee, Hakmin, et al.
Publicado: (2017)

Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma
por: Tucker, Matthew D., et al.
Publicado: (2020)

Resistance to cancer immunotherapy in metastatic renal cell carcinoma
por: Moreira, Marco, et al.
Publicado: (2020)

Prognostic significance of platelet–lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer
por: Park, Tae Ju, et al.
Publicado: (2016)

The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Machine learning-based prediction model for late recurrence after surgery in patients with renal cell carcinoma
por: Kim, Hyung Min, et al.
Publicado: (2022)

Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium model
por: Shin, Dongrul, et al.
Publicado: (2021)

Machine learning based prediction for oncologic outcomes of renal cell carcinoma after surgery using Korean Renal Cell Carcinoma (KORCC) database
por: Kim, Jung Kwon, et al.
Publicado: (2023)

Immunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review
por: Raman, Rachna, et al.
Publicado: (2015)

The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
por: Rathi, Nityam, et al.
Publicado: (2019)

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Nonmetastatic Renal Cell Carcinoma: A Large, Multicenter Cohort Analysis
por: Byun, Seok-Soo, et al.
Publicado: (2016)

Small (<4 cm), Unclassified Renal Cell Carcinoma Presenting with Initial Bone Metastasis: A Case of a Metastatic Lesion Missed at the Initial Diagnosis
por: Lee, Seung Je, et al.
Publicado: (2012)

The establishment of KORCC (KOrean Renal Cell Carcinoma) database
por: Byun, Seok-Soo, et al.
Publicado: (2016)

Transurethral Foley catheter misplacement into the upper urinary tract in a patient with a history of lung cancer and chemotherapy: a case report and considerations to keep in mind
por: Cho, Soo Kyung, et al.
Publicado: (2021)

Effects of leuprolide acetate on the quality of life of patients with prostate cancer: A prospective longitudinal cohort study
por: Kim, Myung Soo, et al.
Publicado: (2021)

The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma
por: Garje, Rohan, et al.
Publicado: (2020)

The components of tumor microenvironment as biomarker for immunotherapy in metastatic renal cell carcinoma
por: Su, Jiaming, et al.
Publicado: (2023)

Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma
por: Chatwal, Monica Sheila, et al.
Publicado: (2023)

Metastasis of renal cell carcinoma around suture anchor implants
por: Baek, Samuel, et al.
Publicado: (2021)

Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
por: Lee, Ji Hyun, et al.
Publicado: (2023)

Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study
por: Kang, Ho Won, et al.
Publicado: (2016)

Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports
por: Tucker, Matthew D., et al.
Publicado: (2020)

Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma
por: Dawsey, Scott J., et al.
Publicado: (2021)

Immunotherapy and Metastatic Renal Cell Carcinoma: A Review of New Treatment Approaches
por: Kathuria-Prakash, Nikhita, et al.
Publicado: (2021)

Impact of preoperative thrombocytosis on prognosis after surgical treatment in pathological T1 and T2 renal cell carcinoma: results of a multi-institutional comprehensive study
por: Ha, Yun-Sok, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3mi45o8g21jneqdj618rq3gbs1